Brief: Clearmind Medicine Announces Successful Completion Of Second Cohort Enrollment
16/12/2025 15:05
Dec 16 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF SECOND COHORT ENROLLMENT IN ONGOING FDA-APPROVED PHASE I/IIA TRIAL FOR CMND-100 Source text: ID:nGNXXXpQf Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM